Ellen Relkin, of counsel attorney for Weitz and Luxenberg’s team focusing on defective drugs and medical devices, has been filing lawsuits against the manufacturers of Invokana. Those manufacturers are Janssen Pharmaceuticals, and its affiliated companies Mitsubishi Tanabe Pharmaceuticals and Johnson & Johnson. She spoke about the injuries this drug is causing, including diabetic ketoacidosis, with The Legal Intelligencer. Read more at Pa. Becoming Destination for Growing Invokana Litigation. Cases filed by Weitz and Luxenberg also include those for serious injuries involving urinary sepsis and kidney damage, as well as the consequences of these problems, such as prolonged coma, sepsis and necrotizing fasciitis.
Weitz & Luxenberg Practice Group Co-Chair Ellen Relkin has been selected by the New Jersey Association for Justice (NJAJ) to receive the prestigious Gerald B.…Read More